1652.HK

Fusen Pharmaceutical Company Limited [1652.HK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

1652.HK Stock Summary

Top 10 Correlated ETFs

1652.HK

Top 10 Correlated Stocks

1652.HK

In the News

1652.HK Financial details

Company Rating
-
Market Cap
667.35M
Income
-11.11M
Revenue
662.58M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.15K
Optionable
No
Shortable
Yes
Earnings
29 Mar 2024
P/E
-26.79
Forward P/E
-
PEG
1.33
P/S
1.86
P/B
1.51
P/C
-
P/FCF
10.56
Quick Ratio
0.18
Current Ratio
0.85
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-329%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.25%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-13.79%
SMA50
-48.98%
SMA100
-72.53%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-5%
ROC
0.03%
Gross Margin
46%
Oper. Margin
3%
Profit Margin
-7%
Payout
-20%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.9-1.6
52W High
-
52W Low
-
RSI
46.53
Rel Volume
0.06
Avg Volume
138.76K
Volume
9K
Perf Week
5.69%
Perf Month
1.96%
Perf Quarter
-72.63%
Perf Half Y
-71.11%
-
-
-
-
Beta
0.225
-
-
Volatility
0.01%, 0.02%
Prev Close
0%
Price
0.26
Change
6.56%

Something similar

Top by Market Cap
AVGO
GOOGL
VFINX
AAPL
0YXG.L
Top Correlated ETFs
3040.HK
3167.HK
83147.HK
BRIC.SW
EZNC.MI
Top Correlated Stocks
2779.HK
0RNP.L
0HTF.L
1173.HK
6189.HK
Similar Market Cap
KREF
FBT.L
EUSA
RDUS
KMD.NZ

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 138.76K
  • Market Capitalization 667.35M
  • Employee 1.15K
  • CEO Mr. Zhiming Cao
  • Headquarters Nanyang,CN
  • IPO Date 2018-07-11
  • Website https://www.fusenyy.com

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.